TG Therapeutics (TGTX) Chief Executive Michael Weiss says his biotech company is small, but "mighty." But the move put up by TG stock over the last year has been anything but small. After hitting a fresh low in October 2023 below 7 a share, TG Therapeutics shares have rocketed more than 470%, touching a recent high near 37 in November…
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.